longbridge
  • Explore
    Products
    Private Wealth ManagementUS StocksSG StocksHK StocksUS OptionsUS Pre-Market OptionsETFsREITsWarrantsCash Plus
    Tools
    Longbridge SkillLongbridge AILongbridge APIPaper TradingDividend HubLongbridge Pro
  • Café
longbridge

BIOCYTOGEN-B

2315

36.9603.50% ( -1.340 )
Delay Closed: Nov 18, 16:08:04
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile

News

  • Weekly Recap | BIOCYTOGEN-B -0.72%, consensus target above spot

    Weekly Review·Nov 14, 2026 at 05:18 AM
    02315-3.50%
  • Biocytogen climbs 6%

    Market Movers·Nov 10, 2026 at 01:32 AM
    02315-3.50%
  • Weekly Recap | BIOCYTOGEN-B +5.86%, consensus target above spot

    Weekly Review·Nov 7, 2026 at 05:46 AM
    02315-3.50%
  • Biocytogen falls 8%

    Market Movers·Nov 6, 2026 at 01:31 AM
    02315-3.50%
  • Biocytogen surges 12%

    Market Movers·Nov 4, 2026 at 05:39 AM
    02315-3.50%
  • Biocytogen drops 6%

    Market Movers·Nov 3, 2026 at 05:05 AM
    02315-3.50%
  • Biocytogen Pharmaceuticals (SEHK:2315) Stock Sinks Despite Profitable Q3 Results

    Simplywall·Oct 30, 2026 at 12:53 PM
    02315-3.50%688796-2.14%
  • Biocytogen tumbles 12%

    Market Movers·Oct 30, 2026 at 01:50 AM
    02315-3.50%
  • Biocytogen climbs 6% as CRO leader WuXi AppTec raises guidance

    Market Movers·Oct 28, 2026 at 01:49 AM
    02315-3.50%
  • Weekly Recap | BIOCYTOGEN-B -15.58%, a full-week slide

    Weekly Review·Oct 24, 2026 at 05:19 AM
    02315-3.50%
  • Cytogen Extends Equipment Supply Contract Deadline to Dec. 4, 2026

    PUBT·Oct 20, 2026 at 08:06 AM
    02315-3.50%
  • Weekly Recap | BIOCYTOGEN-B -18.88%, a steady one-way pullback

    Weekly Review·Oct 17, 2026 at 05:39 AM
    02315-3.50%
LongbridgeAI
© 2026 Longbridge|Terms of ServicePrivacy Policy